Morrie Olson

• Oversee all aspects of agency functioning, administrative, fiscal, clinical, and external interagency relationships.
• Initiated key changes to the Admissions role resulting in achieving increased census and bed expansion.
• Improved daily functioning of Admissions role, while diminishing line-item expense.
• The introduction of a severity rating for prospective client reviews to establish consistency in the resident population.
• Subsequently, the census was increased and expanded post-Covid limitations and a waiting list established.
• Enhanced resident Monitor/Technician effectiveness through acquisition of an experienced Lead Monitor position, and established increased guidance of medication administration.
• Wait time for beds held for patients requiring Medication Assisted Treatment (MAT) and psychiatric medications, was reduced by fostering new Agency relationships with a private practice psychiatric nurse practitioner and an additional prescriber for all available MAT meds.
• These relationships with external professionals also contribute to agency recommendations for referrals via their affiliations.
• Improved facility appearance by acquisition skilled maintenance position.
• Counseling staff scheduling was made consistent among all employees requiring less part-time staff.
• Restructured the Admissions role establishing greater patient continuity in the resident mix.
• Established a severity rating scale to communicate the level of patient functioning to others involved in the admissions review process.
• Instituted unified counselor responsibilities and scheduling.
• Provides professional pharmacologic review of resident medications.
• Updated existing, and created new, policies and procedures to benefit residents and unify staff understanding and performance.
• Directed strategic planning initiatives to enhance service delivery and operational efficiency.
• Oversaw compliance with regulatory standards in mental health counseling practices.
• Implemented quality assurance measures to maintain high standards of client care.
• Facilitated partnerships with local organizations to enhance service accessibility for clients.
• Championed staff training sessions to promote professional development and skill enhancement.
• Managed the organization's financial resources and operations to maximize efficiency and effectiveness.
• Evaluated existing programs for improvement opportunities while identifying new program ideas based on market analysis.
• Strengthened company business by leading implementation of new projects and procedures.
• Stayed up-to-date on best practices and cutting-edge ideas to improve organizational effectiveness.
• Recommended appropriate staffing techniques to meet demands and manage costs.
• Performed risk assessments across multiple areas of operations in order to identify potential issues before they arise.
• Successfully improved employment turnover through creating incentive and training programs.
• Created program to promote new managers from within, leading to cohesive leadership structure.

• Utilizing expertise in buprenorphine, (Suboxone), to train/educate physician and provide overall practice guidance for Behavioral Health private practice start-up.
• Training and Education for M.A.T. Business Start-up.
• Physician training in buprenorphine induction and maintenance.
• Establish Practice clinical requirements, MAT procedures and forms institution.
• Evaluate patients for medication suitability and maintenance.
• Review each patient’s information with physician.
• Offer medication recommendation for dosing with physician.
• Monitor patient detoxification and initial maintenance dosing.
• Trained staff on best practices in behavioral health management techniques.
• Attended weekly supervision meetings where cases were discussed and feedback was given.
• Advised physicians on changes or adjustments needed in medications when necessary.
• Participated in assessments and visits with patients in various types of settings.
• Engaged in continuous professional development to stay current with the latest research and best practices in behavioral health.
• Participated in case conferences and team meetings to discuss complex cases and share insights with colleagues.

Employs clinical expertise with opioid medications among pain-dependent and substance-abusing populations, identifying specific variables for clinically driven outcome analysis using advanced machine learning algorithms.

Reviewed potential data points to be focussed upon for determining the applications of information obtained from machine learning platform for clinical use.

• Spearheaded all clinical programming, policy determination and review, and medication-related decision-making as member of Executive Management Team.
• Fostered relationships with external stakeholders and members of internal cross-functional teams to streamline operations, coordinate clinical services, and deliver expected outcomes.
• Promoted personal and professional development through training and mentoring.
• Guided and motivated team of 25 – 30 directors, managers, and personnel while administrating multi-million-dollar budget and allocating resources to complete all day-to-day activities and special projects related to clinical department areas, admissions, and detoxification services in a timely, economical, and high-quality planner.
• Authored, improved, and enforced policies, procedures, and best practices.
• Provided clinical determination support for admissions assessments alongside Medical Director and Lead CRNP-Psych.
• Identified problems and implemented solutions to better streamline operations.
• Collaborated with executive team members on major decisions regarding company-wide initiatives.

• Drew on best practices, applicable regulations, and organizational procedures to optimize medication provision and elevate the overall quality of care.
• Determined plan coverage type (Medicare, Part D. commercial, etc.) and apply plan-specific guidelines utilizing multiple plan-specific formularies and working with Plan Account Managers to rapidly resolve any issReview chronic and acute disease-state treatments while following standardized clinical guidelines to drive decisions in order to make final clinical determinations for approving or denying funding.
• Performed telephonic evaluations with patients weekly to gauge global level of functioning and relevant behaviors that may influence treatment; review medication regimens, allergies, and potential drug interactions; and discuss treatment, potential changes and improvements, and utilization/compliance.
• Submitted changes to the prior authorization criteria for clinical accuracy for opioids such as Fentanyl and Buprenorphine to mitigate risks to patients and organization related to potential abuse and harm.

ntifesProvided outstanding patient care with focus on addressing needs of individuals, couples and families, seeking to resolve a broad variety of presenting problems, which included, relational issues and addictive behaviors, with and without comorbid mental health disorders.

• Conducted all aspects of practice management, developing treatment and practice improvement protocols and quality measures.
• Assessed and treated addictions through direct patient care and the provision of training, education, and medication protocols.
• Referring to, and interacting with primary care physicians, and other prescribing professionals.
• Indentifying and recommending appropriate referalls, when needed to provided comprehensive care.

Entrusted to represent the organization nationally in support of National Account Managers in both the public, and private sector initiatives, while also supporting the development of new MSL teams as the first, and for a period, only MSL.

• Helped develop clinical, scientific, and marketing materials; determine and prioritize enterprise-wide priorities of product-specific information; develop future CNS and behavioral health pipeline initiatives; and select Key Opinion Leaders (KOL) and independent investigator initiatives/studies.
• Educated staff on MSL role and utilization.
• Leveraged connections to facilitate relationships between city administrators and Public Sector team leader, to enable significantly increased sales volume.
• Delivered engaging presentations for national payor accounts on clinical and scientific data as related to new product information to augment product knowledge resulting in greater sales.
• Represented company and products at national Drug Use Review (DUR) meetings, Pharmacy Benefits Management (PBM) formulary introduction and review, and with national public-sector representatives.

dCompany Overview: (Indivior)

• Served as first in this role supporting public-and private-sector Managed Care teams with specific focus on addressing substance dependence treatment and behavioral healthcare.
• Conveyed clinical product information to physicians and executive leaders of managed healthcare companies.
• Engaged in drug coding and adverse event reporting in support of Registered Nursing team.
• Conducted global company pharmacovigilance and drug safety evaluations for all reported adverse events using MedRa and WHO.
• Trained staff to be clinical liaisons on psychotherapeutic approaches for the treatment of substance use disorder as well as on ancillary medications.
• Assisted with development of clinical pharmacologic and psychotherapeutic-related trainings for Marketing team.
• Crafted and provided compelling presentations for Public-Sector team at DUR and Pharmacy and Therapeutics (P&T) committee meetings and supported endeavors of National Account Management team.
• Fielded escalated inquiries from physicians and other healthcare professionals via medical information hotline.
• Led team tasked with producing comprehensive FDA-required annual Periodic Summary Review Update Report (PSUR) within demanding timeline.
• Partnered with large State oversight providers of behavoral health medication provision, to utilize their large data banks for review and analytics regarding buprenorphine.
• Testified before State Senate sub-committees and Governor’s panels regarding suboxone (buprenorphine).

s'footEstablished the initial programmatic policies, and initiatives, forging relationships with 120+ treatment provider agencies and City/State officials to enable organizational growth from 1.8 M. as the former Act 152 Project to 28M.

• Supervised the clinical and administrative aspects of the program, harmoniously uniting funding delivery and case management.ment.
• Reported to the Assistant Health Commissioner of Philadlephia, PA. repsonsible for the City's substance abuse services. delivery.
• Steered $20M+ ACT 152/BHSI Behavioral Health Managed Care Program to ensure comprehensive funding source for all levels of treatment for co-occurring disorders with primary substance abuse.
• Co-authored and directed successful funding requirement submissions for PA’s largest Targeted Case Management Program.
• Decisively implemented policies, balanced budgets, and recommended changes to provider agencies to enhance quality of treatment delivery.

• Strategized and coordinated all psychopharmacology-related activities, reporting directly to Director of Research Division.
• Identified projects aligned with business objectives and ethical standards, produced proposals, and secured funding from various agencies.
• Trained team of 20, providing constructive evaluations and ongoing mentoring to drive professional growth.
• Oversaw program development, generated data-driven reports, and produced publications.

• One of five initial practitioners chosen to initiate the Center’s treatment-research protocols and related activities.
• Provided family focused psychotherapy and addictions counseling, and providing pharmaceutical consultation to the treatment team.
• Conducted oversight of medication procurement and distribution, along with liaison activities to principal investigators of research studies and clinical service providers to ensure the efficacy of research protocols.
• Functioned as a member of the Executive Committee and decision-making work teams to determine processes and implementation of study activities.
• Oversaw and managed medication distribution for placebo controlled trials.